HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
Abstract Purpose The role of HHLA2, a new immune checkpoint ligand, is gradually being elucidated in various solid tumours. However, its role in ovarian cancer remains unclear; thus, its expression profile and clinical significance in ovarian cancer must be examined. Methods We performed immunohisto...
Main Authors: | Guocai Xu, Yuanyuan Shi, Xiaoting Ling, Dongyan Wang, Yunyun Liu, Huaiwu Lu, Yongpai Peng, Bingzhong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-01930-y |
Similar Items
-
Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
by: Luo M, et al.
Published: (2021-08-01) -
Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
by: Luo M, et al.
Published: (2021-09-01) -
Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
by: Zhu Z, et al.
Published: (2018-03-01) -
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
by: Chu-Yu Jing, et al.
Published: (2019-03-01) -
Prognostic Significance of Potential Immune Checkpoint Member HHLA2 in Human Tumors: A Comprehensive Analysis
by: Ben Wang, et al.
Published: (2019-07-01)